Abstract
Background: The effect of recent exposure to illicit substances on the hypothalamic-pituitary-thyroid axis hormones during acute psychiatric hospitalization remains largely unknown. The aim of this study was to examine thyroid stimulating hormone (TSH) levels in patients admitted to the Los Angeles County hospital psychiatric emergency room with positive urine toxicology screening [Utox(+)]. Methods: The medical records of all patients admitted to the psychiatric emergency room (ER) (2002-2007) were reviewed (n=18,836) to extract TSH and Utox data. Serum TSH levels are routinely measured by radioimmunoassay and Utox is routinely tested using the enzyme immunoassay technique as part of clinical care. A general linear model was used to compare geometric mean TSH values between Utox(+) and Utox(-) groups adjusting for age, sex, and race. Results: Utox data were available for 57% (n=4,470) of final study cohort. 39% (n=1,726) were Utox(+). A significant race effect on TSH levels was detected regardless of Utox(+) status, with African American patients having significantly lower mean TSH compared with non-Hispanic white patients: 0.98 ± 2.19 vs. 1.29 ± 2.43, mean ± SD, P<0.0001). Furthermore, TSH levels were significantly lower in the Utox(+) group compared with the Utox(-) group (1.01 ± 2.41 vs. 1.26 ± 2.26, P<0.0001) adjusted for age, gender, and race. Within the Utox(+) group, there was no significant gender difference observed (males vs. females: 1.00 ± 2.32 vs. 1.04 ± 2.57, P=0.1). Conclusion: We observed an association between Utox(+) status and low serum TSH levels in both males and females admitted for acute psychiatric conditions. While the stress caused by acute substance intoxication or withdrawal may play a role in altering TSH levels in this group of patients, the neuroendocrinological underpinnings of this observation require further research.
Highlights
Large scale epidemiological studies document high prevalence of substance use disorders among the general population and more so among psychiatric patients [1,2,3,4,5,6,7]
Almost one‐third of all patients enrolled in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study [8] and about two‐thirds of patients suffering from bipolar disorder [9] have a co-morbid substance use disorder diagnosis
It is not entirely clear, how much impact mental illnesses, substance use disorders, the stress associated with psychiatric hospitalization, or intoxication/withdrawal have on the observed change in thyroid stimulating hormone (TSH) levels
Summary
Large scale epidemiological studies document high prevalence of substance use disorders among the general population and more so among psychiatric patients [1,2,3,4,5,6,7]. Abnormal TSH results are seen in 7%-24% of patients during acute psychiatric hospitalization [10,11,12,13,14,15,16,17,18,19,20]. Spontaneous normalization of TSH tends to be the trend in most cases. It is not entirely clear, how much impact mental illnesses, substance use disorders, the stress associated with psychiatric hospitalization, or intoxication/withdrawal have on the observed change in TSH levels. The aim of this study was to examine thyroid stimulating hormone (TSH) levels in patients admitted to the Los Angeles County hospital psychiatric emergency room with positive urine toxicology screening [Utox(+)]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.